Efficacy and safety of escitalopram in treatment of severe depression in Chinese population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of escitalopram in treatment of severe depression in Chinese population

Published:2017-03-15 Issue:3 Volume:32 Page:891-901
ISSN:0885-7490
Container-title:Metabolic Brain Disease
language:en
Short-container-title:Metab Brain Dis

Author:

Si Tianmei,Wang Gang,Yang Fude,Fang Yiru,Fang Maosheng,Li Jijun,Dong Jicheng,Shen Xinhua,Zhuo Jianmin,Rui Qing,Wang Jinan,Cuili Hu

Funder

Xi'an Janssen Pharmaceutical Ltd. Beijing, China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Biochemistry

Link

http://link.springer.com/article/10.1007/s11011-017-9992-5/fulltext.html

Reference50 articles.

1. Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I (2005) Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 3:449–456. doi: 10.1370/afm.349

2. Baldwin DS, Cooper JA, Huusom AK, Hindmarch I (2006) A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int Clin Psychopharmacol 21:159–169. doi: 10.1097/01.yic.0000194377.88330.1d

3. Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS (2007) Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo. Pharmacopsychiatry 40:152–156. doi: 10.1055/s-2007-984398

4. Bose A, Tsai J, Li D (2012) Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine. Clin Drug Investig 32:373–385. doi: 10.2165/11631890-000000000-00000

5. Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M (2006) A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Curr Med Res Opin 22:1331–1341. doi: 10.1185/030079906x115513

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using functional near-infrared spectroscopy to study effects of virtual reality intervention for adolescents with depression in a clinical setting in China: study protocol for a prospective, randomised, controlled trial;BMJ Open;2023-12

2. THERAPY OF POST-COVID DEPRESSION: A PROACTIVE PSYCHOSOMATIC APPROACH;Polski Merkuriusz Lekarski;2023

3. Neural mechanism of the relationship between sleep efficiency and clinical improvement in major depressive disorder: A longitudinal functional magnetic resonance imaging study;Frontiers in Psychiatry;2022-10-03

4. Comparative Analysis of the Effects of Escitalopram, Pramipexole, and Transcranial Magnetic Stimulation on Depression in Patients With Parkinson Disease: An Open-Label Randomized Controlled Trial;Clinical Neuropharmacology;2022-02-01

5. Do the successful revision surgery for humeral nonunion solve all the effects on health‐related quality of life? A retrospective cohort study;BMC Musculoskeletal Disorders;2021-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3